SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-05-003483
Filing Date
2005-12-23
Accepted
2005-12-23 15:35:08
Documents
4
Period of Report
2005-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS INC 8-K 12-22-05 peregrine-8k_122205.htm 8-K 29166
2 FIRST AMENDMENT TO LEASE ex99-1.htm EX-99.1 64123
3 TNCA LETTER ex99-2.htm EX-99.2 19199
4 PEREGRINE LOGO logo.jpg GRAPHIC 14610
  Complete submission text file 0001019687-05-003483.txt   134467
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17085 | Film No.: 051285408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances